Subject index volume 51

The N&he&

ELSEVIER.

JOURNAL OF MEDICINE Netherlands

Journal

of Medicine

51 (1997)

245-246

Subject Index Volume 5 1 Abdominal tuberculosis, (5 1) 119 Actinomyces meyeri, (5 1) 39 Actinomycosis, disseminated, (51) 39 Acute folate deficiency, (51) 36 Adrenal enlargement, (51) 146 Adverse effect, (51) 110 Adverse effects, (51) 114 Amiodarone, (5 1) 163 Antibiotics, (51)~ 154 Antibiotic treatment, (51) 83 Antimicrobials, (5 1) 154 Antithrombotic treatment, (5 1) 5 1 Ascites, (51) 123 Aspirin, (51) 51 Atherosclerosis, (51) 16

Echography, (5 1) 119 Encephalitis, (51) 79 Endobronchial, (5 1) 143 Epidemiology, (51) 1 Epstein-Barr virus, (51) 79 Erythema exudativum multiforme, (5 1) 114 Erythropoietin, (5 1) 169 Essential tbrombocythaemia, (5 1) 57, (5 1) 110 European Union, (51) 205 F cell production, (51) 169 Fever, diagnosis, (51) 140 Fever of unknown origin, (51) Folate, (51) 36

Gastric protection, (51) 198 Gastroenteritis, (5 1) 83 Gastrointestinal disease, (51) 129 Gastro-oesophageal reflux disease, (5 1) 134 Glascow coma scale, (51) 91 Glucose tolerance test, (51) 96 Good post-marketing surveillance practice, (51) 20.5 Granulocytopenia, (51) 36

Bs haplotype, (Sl) 169 Brain stem reflexes, (51) 91 Breast cancer, 01) 65 Butyrate, (51) 169 Cardiac arrest, (51) 91 Case-control study, (51) 163 Case report, (5 11 87 Cephalosporins, (51) 123 Cerebellitis, (5 1) 79 Chemotherapy, (5 1) 30 Cholesterol lowering, (51) 16 Chronic HCV infection, (51) 213 Chronic megakaryocytic granulocytic Chronic myeloproliferative syndromes, Clinical severity, (51) 169 Clinical trial, (5 1) 10 Colorectal varices, (51) 187 Coronary artery disease, (51) 16 Coronary heart disease, (51) 1 Cryoglobulinaemia, (51) 225 Cycle-oxygenase, (5 1) 198 Cytokines, (51) 140 Diagnosis, (51) 129 Drug fever, (51) 110, (51) 114

140

metaplasia, (51) 114

(5 1) 57

Haemolytic uraemic syndrome, (51) 103 Haemorrhagic cystitis, (51) 228 HCV antiviral therapy, (51) 213 HDL cholesterol, (51) 1 Helicobacter pylori, (51) 129 Hepatitis C virus, (51) 213, (51) 225 Hepatocellular adenoma, (5 1) 46 High-volume venovenous haemofiltration, (5 1) 36 HIV, (51) 103 Hydroxyurea, (51) 110, (51) 114, (51) 169 Ibopamine, (5 1) 163 Immunological reaction, (5 1) 110 Infectious mononucleosis, (51) 79 Insulin, (51) 96 Intellectual disability, (51) 134 Interferon 0, (51) 225 Interleukin-1, (51) 140

246

Interstitial Intracranial

nephritis, (51) 228 haemorrhage, (5 1) 5 1

LDL-cholesterol, (51) 16 Leptin, (5 1) 96 Lipoma, (51) 143 Liver cirrhosis, (51) 123 Liver function test abnormalities, Lung, (51) 143 Lyme disease, (51) 154

Public health, (5 I) I Pulmonary oedema, (5 1) 182 Puncture, (51) 1 19 Quinolones,

Radiographic finding, (5 1) 179 Regulations, (5 1) 205 Renin-angiotensin system, (51) 232

(5 1) 114

Macroglobulinaemia, (51) 140 Mortality, (51) 163 Myeloproliferative disorders, (51) 57 Neurological outcome, (5 1) 91 Non steroidal anti-inflammatory drug, (51) Non-valvular atrial fibrillation, (51) 5 1 NSAID, (51) 228 Obesity, (51) 96 Omeprazole effective, (51) 134 Oral contraceptives, (5 1) 46 Ovarian hyperstimulation syndrome, Pancreatitis, (5 1) 187 Perinatal infection, (5 1) 83 Peripheral vascular disease, (5 1) 16 Pharmacodynamics, (51) 30 Pharmaco-epidemiology, (51) 163 Pharmacoepidemiology, (5 1) 205 Pharmacokinetics, (5 1) 30 Pleural effusion, (5 1) 232 Polycythaemia Vera, (51) 57 Predictive factors, (51) 213 Pregnancy, (51) 83 Prevention, (51) 83 Prognostic factors, (51) 65 Prostaglandin, (51) 198

(5 1) 123

198

(51) 232

Salmonella enferitidis, (51) 83 Side-effect, (51) 198 Somatosensory evoked potentials, (51) 91 Splenic vein thrombosis, (51) 187 Spontaneous bacterial peritonitis, (51) 123 Stroke, (51) 51 Supravalvular aortic stenosis, (51) 182 Supravalvular pulmonary stenosis, (51) 182 Survey, (51) 129 Takayasu’s arteritis, (51) 182 Therapeutics, (5 1) 10 Thoracentesis, (5 1) 232 Thrombocytopenia, (5 1) 36 Thromboembolism, (51) 51 Thrombotic thrombocytopenic purpura, Thymus, (51) 87 Tiaprofenic acid, (5 1) 228 Total cholesterol, (51) 1 Treatment, (51) 129, (51) 179 Tuberculosis, (S 1) 87 Urticaria, Vasculitis,

(51) (51)

140 140, (51) 146

Warfarin, (51) 51 Weight loss, (51) 96 Wilkie’s syndrome, (51)

179

(5 1) 103